Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

BACKGROUND: The risk-benefit ratio of aspirin therapy in prevention of cardiovascular disease (CVD) remains contentious, especially in type 2 diabetes. This study examined the benefit and harm of low-dose aspirin (daily dose < 300 mg) in patients with type 2 diabetes. METHODS: This is a longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Wilson Y, So, Wing-yee, Stewart, Derek, Lui, Augustine, Tong, Peter C, Ko, Gary T, Kong, Alice P, Ma, Ronald C, Chan, Francis K, Yang, Xilin, Chiang, Sau-chu, Chan, Juliana C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777137/
https://www.ncbi.nlm.nih.gov/pubmed/19878541
http://dx.doi.org/10.1186/1475-2840-8-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777137/
https://www.ncbi.nlm.nih.gov/pubmed/19878541
http://dx.doi.org/10.1186/1475-2840-8-57

Ejemplares similares